IYHvsXLVIETF Comparison
VS
ETF 2
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.17%
iShares U.S. Healthcare ETF (IYH) belongs to the US Health Care segment. State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) is part of the Options Strategies segment. IYH's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, XLVI's top sector exposures are Healthcare and Consumer Non-Cyclicals. IYH is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.35% for XLVI. IYH is up 5.7% year-to-date (YTD) with -$362M in YTD flows. XLVI performs worse with 5.2% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of IYH and XLVI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IYH vs XLVI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IYH XLVI | +5.82%+3.88% | +13.09%+7.81% | +5.70%+5.20% | +21.44%n/a | +24.36%n/a | +28.54%n/a |
| Flows | IYH XLVI | +$40M+$2M | +$152M+$5M | -$362M+$7M | +$71M- | -$426M- | +$33M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IYH XLVI | +18.28%+12.38% | +15.81%n/a | +14.55%n/a | +15.22%n/a |
| Max drawdown | IYH XLVI | -4.09%-2.06% | -10.72%n/a | -17.89%n/a | -17.89%n/a |
| Max drawdown duration | IYH XLVI | 17d7d | 169dn/a | 445dn/a | 445dn/a |
Trading data
IYH | XLVI | |
Last sale 7/24/2026 at 1:30 PM | $68.41 | $26.52 |
| Previous close 07/23/2026 | $67.98 | $26.33 |
| Consolidated volume 07/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLVI
is actively managed and doesn’t replicate an indexIYH | XLVI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
IYH | XLVI | |
|---|---|---|
| Last price | $68.41 | $26.52 |
| 1D performance | +0.63% | +0.72% |
| AuM | $3.37 B | $18.27 M |
| E/R | 0.38% | 0.35% |
Characteristics
IYH | XLVI | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | State Street Investment Management |
| Benchmark | Russell 1000 Health Care RIC 22.5/45 Capped Gross Index | - |
| N° of holdings | 101 | 59 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2000 | July 30, 2025 |
| ESG | No | No |
Advertisement
Exposure
Countries
IYH
USA
97.03%
Other
2.97%
XLVI
USA
100.53%
Other
-0.53%
Sectors
IYH
Healthcare
99.86%
Other
0.14%
XLVI
Healthcare
100.33%
Other
-0.33%
Diversification
IYH
Total weight of top 15 holdings out of 15
69.73%
XLVI
Total weight of top 15 holdings out of 15
74.76%
Top 15 holdings
Data as of June 30, 2026
IYH
Eli Lilly & Co.
16.07%
Johnson & Johnson
10.27%
AbbVie, Inc.
7.48%
UnitedHealth Group, Inc.
6.30%
Merck & Co., Inc.
5.34%
Amgen, Inc.
3.28%
Thermo Fisher Scientific, Inc.
3.13%
Abbott Laboratories
2.64%
Gilead Sciences, Inc.
2.63%
Intuitive Surgical, Inc.
2.35%
Pfizer Inc.
2.30%
Vertex Pharmaceuticals, Inc.
2.12%
Danaher Corp.
2.02%
Bristol Myers Squibb Co.
1.97%
Stryker Corp.
1.83%
XLVI
Eli Lilly & Co.
17.01%
Johnson & Johnson
10.96%
AbbVie, Inc.
7.97%
UnitedHealth Group, Inc.
6.77%
Merck & Co., Inc.
5.69%
Amgen, Inc.
3.50%
Thermo Fisher Scientific, Inc.
3.34%
Abbott Laboratories
2.83%
Gilead Sciences, Inc.
2.81%
Intuitive Surgical, Inc.
2.53%
Pfizer Inc.
2.46%
CVS Health Corp.
2.37%
Vertex Pharmaceuticals, Inc.
2.26%
Danaher Corp.
2.15%
Bristol Myers Squibb Co.
2.11%
Frequently asked questions about IYH and XLVI
How have the IYH and XLVI ETFs performed in 2026?
As of July 24, 2026, IYH is up 5.7% year-to-date (YTD), while XLVI has returned 5.2%. That puts IYH better performer ahead so far this year.
Which ETF is attracting more investor money: IYH or XLVI?
Year-to-date, the IYH ETF saw -$362M in flows, compared to +$7M for XLVI.
Which ETF is bigger: IYH or XLVI?
As of July 24, 2026, IYH holds $3.37 B in assets under management (AUM), while XLVI manages $18.27 M.
What sectors do the IYH and XLVI ETFs invest in?
IYH leans toward sectors like Healthcare. Meanwhile, XLVI focuses on Healthcare.
What are the top holdings of the IYH ETF and XLVI ETF?
IYH top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLVI holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: IYH or XLVI?
IYH holds 101 securities with 69.73% of its assets in the top 15. XLVI has 59 securities and a top 15 weight of 74.76%.
Advertisement
Latest news about IYH & XLVI
Health Care Sector Down After a Cyberattack on UnitedHealth
March 4, 2024
IYH
Healthcare Stocks Rebound
August 14, 2023
IYH
Continued tightening of the U.S. labor market
September 23, 2022
IYH
U.S. labor market facing tight conditions
July 5, 2022
IYH
Advertisement
Advertisement
